reports
Coca Cola Co: 1 director
A director at Coca Cola Co sold 100,000 shares at 64.030USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Moody's Ratings assigns A1 ratings to Coca Cola's Euro notes; outlook ...
Moody's Ratings (Moody's) today assigned A1 ratings to The Coca-Cola Company's ("Coca-Cola") new Euro-denominated senior unsecured notes. All other ratings for the company including the A1 senior unsecured and Prime-1 commercial paper ratings remain unchanged. The rating outlook remains stable. Co...
Moody's Ratings assigns A1 ratings to Coca Cola's USD notes; outlook i...
Moody's Ratings (Moody's) today assigned A1 ratings to The Coca-Cola Company's ("Coca-Cola") new US dollar senior unsecured notes. All other ratings for the company including the A1 senior unsecured and Prime-1 commercial paper ratings remain unchanged. The rating outlook remains stable. Coca-Cola...
- Wedbush Research
PEP PEPSICO INC.
MNST MONSTER BEVERAGE CORPORATION
MGPI MGP INGREDIENTS INC.
BF.B BROWN-FORMAN CORPORATION CLASS B
KO COCA-COLA COMPANY
SAM BOSTON BEER COMPANY INC. CLASS A
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
CELH CELSIUS HOLDINGS INC.
KDP KEURIG DR PEPPER INC.
CURA CURALEAF HOLDINGS
NAPA DUCKHORN PORTFOLIO INC (THE)
CRLBF CRESCO LABS INC.
TCNNF TRULIEVE CANNABIS CORP.
GTBIF GREEN THUMB INDUSTRIES INC.
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Coca-Cola Company (The) and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 14 June 2024 in which Moody's reassessed the appropriateness of the ratings in the ...
- Antoine Legault
- Gerald Pascarelli
- Wedbush Research
XENE XENON PHARMACEUTICALS INC
V VISA INC. CLASS A
TSCO TRACTOR SUPPLY COMPANY
TRIP TRIPADVISOR INC.
SAGE SAGE THERAPEUTICS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
HURN HURON CONSULTING GROUP INC.
GOOGL ALPHABET INC. CLASS A
FL FOOT LOCKER INC.
FATE FATE THERAPEUTICS INC
EXPE EXPEDIA GROUP INC.
DECK DECKERS OUTDOOR CORPORATION
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
AZO AUTOZONE INC.
ARDX ARDELYX INC
AAP ADVANCE AUTO PARTS INC.
KO COCA-COLA COMPANY
TSC TRISTATE CAPITAL HOLDINGS INC
ORLY O'REILLY AUTOMOTIVE INC.
PK PARK HOTELS & RESORTS INC.
CVCO CAVCO INDUSTRIES INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
GM GENERAL MOTORS COMPANY
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
BKNG BOOKING HOLDINGS INC.
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
LYFT LYFT
UBER UBER TECHNOLOGIES INC.
CHWY CHEWY INC. CLASS A
STOK STOKE THERAPEUTICS
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
IDYA IDEAYA BIOSCIENCES
GDYN GRID DYNAMICS
BDTX BLACK DIAMOND THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
COGT COGENT BIOSCIENCES INC
DASH DOORDASH
ABNB AIRBNB INC. CLASS A
IMNM IMMUNOME
VOR VOR BIOPHARMA
WOOF PETCO HEALTH AND WELLNESS
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
LBPH LONGBOARD PHARMACEUTICALS
FOUR SHIFT4 PAYMENTS
IKNA IKENA ONCOLOGY INC
TCRX TSCAN THERAPEUTICS INC
HOWL WEREWOLF THERAPEUTICS INC
FLYW FLYWIRE CORP
GLUE MONTE ROSA THERAPEUTICS INC
CMPX COMPASS THERAPEUTICS
GMTX GEMINI THERAPEUTICS INC
CINT CI&T INC
YOU CLEAR SECURE INC
TOST TOAST INC
HR HEALTHCARE TRUST OF AMERICA INC.
EWTX EDGEWISE THERAPEUTICS INC
NUVL NUVALENT INC
EMBRAC B EMBRACER GROUP AB
- Moshe Katri
Moody's Ratings assigns A1 rating to Coca Cola's Euro notes; outlook i...
Moody's Ratings (Moody's) today assigned an A1 rating to The Coca-Cola Company's ("Coca-Cola") new senior unsecured Euro notes. All other ratings for the company including the A1 senior unsecured and Prime-1 commercial paper ratings remain unchanged. The rating outlook remains stable. Coca-Cola pl...
- Antoine Legault
- Gerald Pascarelli
Moody's Ratings assigns A1 rating to Coca Cola's USD notes; outlook is...
Moody's Ratings (Moody's) today assigned an A1 rating to The Coca-Cola Company's ("Coca-Cola") new US dollar senior unsecured notes. All other ratings for the company including the A1 senior unsecured and Prime-1 commercial paper ratings remain unchanged. The rating outlook remains stable. Coca-Co...
- Antoine Legault
- Gerald Pascarelli
- Antoine Legault
- Gerald Pascarelli
- Wedbush Research
PEP PEPSICO INC.
GPN GLOBAL PAYMENTS INC.
V VISA INC. CLASS A
SQ SQUARE INC. CLASS A
REXR REXFORD INDUSTRIAL REALTY INC.
PYPL PAYPAL HOLDINGS INC
FISV FISERV INC.
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
ETSY ETSY INC.
KO COCA-COLA COMPANY
KDP KEURIG DR PEPPER INC.
CHWY CHEWY INC. CLASS A
- Antoine Legault
- Gerald Pascarelli
- Antoine Legault
- Gerald Pascarelli
- David Carlson
- David Nierengarten
- Dennis Pak
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
NVCR NOVOCURE LTD.
FATE FATE THERAPEUTICS INC
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
KO COCA-COLA COMPANY
TSC TRISTATE CAPITAL HOLDINGS INC
PK PARK HOTELS & RESORTS INC.
RCUS ARCUS BIOSCIENCES
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
IMNM IMMUNOME
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
FHTX FOGHORN THERAPEUTICS
TNGX TANGO THERAPEUTICS
IKNA INC
TCRX IKENA ONCOLOGY INC
TSVT TSCAN THERAPEUTICS INC
FUSN 2SEVENTY BIO INC
P FUSION PHARMACEUTICALS INC
HR PANDORA MEDIA
NUVL HEALTHCARE TRUST OF AMERICA INC.
NUVALENT INC
- Antoine Legault
- Gerald Pascarelli
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.